Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging

Abbott, 2010, Structure and function of the blood-brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 Alsop, 2010, Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease, J. Alzheimer's Dis., 20, 871, 10.3233/JAD-2010-091699 Alsop, 2015, Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia, Magn. Reson. Med., 73, 102, 10.1002/mrm.25197 Armitage, 2011, Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities, Magn. Reson. Imaging, 29, 305, 10.1016/j.mri.2010.09.002 Austin, 2011, Effects of hypoperfusion in Alzheimer's disease, J. Alzheimers Dis., 26, 123, 10.3233/JAD-2011-0010 Barker, 2014, Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia, Brain, 137, 1524, 10.1093/brain/awu040 Barnes, 2016, Optimal acquisition and modeling parameters for accurate assessment of low K trans blood-brain barrier permeability using dynamic contrast-enhanced MRI, Magn. Reson. Med., 75, 1967, 10.1002/mrm.25793 Benarroch, 2008, Neurovascular unit dysfunction: a vascular component of Alzheimer disease?, Neurology, 68, 1730 Binnewijzend, 2014, Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies, Eur. Radiol., 24, 2326, 10.1007/s00330-014-3172-3 Chen, 2011, Advances in perfusion magnetic resonance imaging in Alzheimer's disease, Alzheimer's Dement., 7, 185, 10.1016/j.jalz.2010.04.004 Cramer, 2014, Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients, J. Cereb. Blood Flow Metab., 34, 1655, 10.1038/jcbfm.2014.126 Cramer, 2014, Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI, Neuroimage Clin., 4, 182, 10.1016/j.nicl.2013.12.001 Dai, 2009, Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging, Radiology, 250, 856, 10.1148/radiol.2503080751 De La Torre, 2004, Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics, Lancet Neurol., 3, 184, 10.1016/S1474-4422(04)00683-0 Drachman, 2014, The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimer's disease, Alzheimer's Dement, 10, 372, 10.1016/j.jalz.2013.11.003 Dubois, 2007, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol., 6, 734, 10.1016/S1474-4422(07)70178-3 Farkas, 2001, Cerebral microvascular pathology in aging and Alzheimer's disease, Prog. Neurobiol., 64, 575, 10.1016/S0301-0082(00)00068-X Fazekas, 1993, Pathologic correlates of incidental MRI white matter signal hyperintensities, Neurology, 43, 1683, 10.1212/WNL.43.9.1683 Fischl, 2002, Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain, Neuron, 33, 341, 10.1016/S0896-6273(02)00569-X Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 Haroon, 2004, A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas, J. Magn. Reson. Imaging, 19, 527, 10.1002/jmri.20045 Hawkins, 2005, The blood-brain barrier/neurovascular unit in health and disease, Pharmacol. Rev., 57, 173, 10.1124/pr.57.2.4 Herscovitch, 1985, What is the correct value for the brain blood partition-coefficient for water, J. Cereb. Blood Flow Metab., 5, 65, 10.1038/jcbfm.1985.9 Heye, 2016, Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability, Neuroimage, 125, 446, 10.1016/j.neuroimage.2015.10.018 Hughes, 1982, A new clinical scale for the staging of dementia, Br. J. Psychiatry, 140, 566, 10.1192/bjp.140.6.566 Iadecola, 2010, The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia, Acta Neuropathol., 120, 287, 10.1007/s00401-010-0718-6 Iadecola, 2013, The pathobiology of vascular dementia, Neuron, 80, 844, 10.1016/j.neuron.2013.10.008 Jack, 2010, Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, Lancet Neurol., 9, 119, 10.1016/S1474-4422(09)70299-6 Janota, 2015, Dissecting the contribution of vascular alterations and aging to Alzheimer's disease, Mol. Neurobiol Jelescu, 2011, Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions, J. Magn. Reson. Imaging, 33, 1291, 10.1002/jmri.22565 Jenkinson, 2002, Improved optimisation for the robust and accurate linear registration and motion correction of brain images, Neuroimage, 17, 825, 10.1006/nimg.2002.1132 Keaney, 2015, Autoregulated paracellular clearance of amyloid-across the blood-brain barrier, Sci. Adv., 1, e1500472, 10.1126/sciadv.1500472 Kehoe, 2014, Advances in MRI biomarkers for the diagnosis of Alzheimer's disease, Biomark. Med., 8, 1151, 10.2217/bmm.14.42 Lacalle-Aurioles, 2014, Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease, J. Cereb. Blood Flow Metab., 34, 654, 10.1038/jcbfm.2013.241 Larsson, 2009, Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 tesla, Magn. Reson. Med., 62, 1270, 10.1002/mrm.22136 Larsson, 1992, Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning—a comparison of methods, Magn. Reson. Med., 24, 174, 10.1002/mrm.1910240119 Lavini, 2010, Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population, Magn. Reson. Imaging, 28, 1420, 10.1016/j.mri.2010.06.017 Lecrux, 2011, The neurovascular unit in brain function and disease, Acta Physiol., 203, 47, 10.1111/j.1748-1716.2011.02256.x Li, 2000, Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors, J. Magn. Reson. Imaging, 12, 347, 10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7 Lu, 2004, Determining the longitudinal relaxation time (T1) of blood at 3.0 tesla, Magn. Reson. Med., 52, 679, 10.1002/mrm.20178 Lyros, 2014, Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease, Curr. Alzheimer Res., 11, 18, 10.2174/1567205010666131119235254 Mattsson, 2014, Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment, Brain, 137, 1550, 10.1093/brain/awu043 McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's Dement., 7, 263, 10.1016/j.jalz.2011.03.005 Montagne, 2015, Blood-brain barrier breakdown in the aging human hippocampus, Neuron, 85, 296, 10.1016/j.neuron.2014.12.032 Moroney, 1997, Meta-analysis of the Hachinski ischemic score in pathologically verified dementias, Neurology, 49, 1096, 10.1212/WNL.49.4.1096 Morris, 1993, The clinical dementia rating (CDR): current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a Nicolakakis, 2011, Neurovascular function in Alzheimer's disease patients and experimental models, J. Cereb. Blood Flow Metab., 31, 1354, 10.1038/jcbfm.2011.43 Patlak, 1983, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab., 3, 1, 10.1038/jcbfm.1983.1 Prins, 2015, White matter hyperintensities, cognitive impairment and dementia: an update, Nat. Rev. Neurol., 11, 157, 10.1038/nrneurol.2015.10 Roher, 2012, Cerebral blood flow in Alzheimer's disease, Vasc. Health Risk Manag., 8, 599, 10.2147/VHRM.S34874 Sagare, 2012, Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease, 405 Schabel, 2008, Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences, Phys. Med. Biol., 53, 2345, 10.1088/0031-9155/53/9/010 Scheltens, 1992, Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates, J. Neurol. Neurosurg. Psychiatry, 55, 967, 10.1136/jnnp.55.10.967 Sourbron, 2010, Technical aspects of MR perfusion, Eur. J. Radiol., 76, 304, 10.1016/j.ejrad.2010.02.017 Sourbron, 2013, Classic models for dynamic contrast-enhanced MRI, NMR Biomed., 26, 1004, 10.1002/nbm.2940 Stanimirovic, 2012, Pathophysiology of the neurovascular unit: disease cause or consequence?, J. Cereb. Blood Flow Metab., 32, 1207, 10.1038/jcbfm.2012.25 Taheri, 2011, Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping, Magn. Reson. Med., 65, 1036, 10.1002/mrm.22686 Tofts, 1999, Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols, J. Magn. Reson. Imaging, 10, 223, 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S Uh, 2010, Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity, Neurobiol. Aging, 31, 2038, 10.1016/j.neurobiolaging.2008.12.010 van de Haar, 2016, Blood-brain barrier leakage in early Alzheimer's disease, Radiology, 10.1148/radiol.2016152244 van der Elst, 2006, The letter digit substitution test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex, J. Clin. Exp. Neuropsychol., 28, 998, 10.1080/13803390591004428 Van Osch, 2009, Can arterial spin labeling detect white matter perfusion signal?, Magn. Reson. Med., 62, 165, 10.1002/mrm.22002 Wechsler, 1997 Zlokovic, 2005, Neurovascular mechanisms of Alzheimer's neurodegeneration, Trends Neurosci., 28, 202, 10.1016/j.tins.2005.02.001 Zlokovic, 2011, Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders, Nat. Rev. Neurosci., 12, 723, 10.1038/nrn3114